Advisory Committee Vacancies Remain High As FDA Revs Up Search
This article was originally published in The Tan Sheet
Executive Summary
With its recent hiring push drawing attention, FDA is quietly undertaking another recruitment effort - filling advisory committee roster vacancies
You may also be interested in...
FDA Works To Fill Advisory Panel Seats While Tightening Conflict Rules
FDA is working on an initiative to bring current advisory committee vacancies from around 30 percent down to 10 percent of its more than 600 spots without backing down from a strict conflict-of-interest policy that many see as contributing to the difficulty in filling the seats
Meet The NDAC, Minus One, As Conflict Of Interest Rules Come Into Play
New Nonprescription Drugs Advisory Committee member James Kehrer's expertise on acetaminophen toxicity should make him a key figure at FDA's upcoming meeting on the drug, he says
FDA Using More Temporary Advisory Committee Members To Fill Vacancies
FDA advisory committees are increasingly relying on temporary members to fill their ranks - a trend that could result in less predictability for drug sponsors at a make-or-break review meeting